Furthermore, ERK3 enhances the activity of tyrosyl DNA phosphodiesterase 2 (TDP2) in DNA damage response and increases the chemoresistance of lung cancer cells to topoisomerase‐2 inhibitors (Bian et al., 2016). The gene discussed is TDP2; the disease is lung carcinoma.